Patent · US Active

Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5

US10633425B2 · kind B2 · utility

4Cited by

16References

6Claims

0Family size

Assignee

Silver Creek Pharmaceuticals, Inc. · US

Inventors

Laura D.J. Antipov · Oakland, US
Shawdee Eshghi · Oakland, US
Kristopher M. Kuchenbecker · San Francisco, US
Bjorn L. Millard · Orinda, US
Matthew Onsum · Corona, US
Andrea D. Nickerson · San Francisco, US
Timothy R. Stowe · San Francisco, US
Yan Zhang · San Francisco, US

Key dates

Filing date	Jul 3, 2018
Grant date	Apr 28, 2020
Priority date	—
Expiry date	Jul 3, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/75
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.